Preview

Pacific Medical Journal

Advanced search

Analysis of the consumption of antibacterial medications in community-acquired pneumonia in children

https://doi.org/10.34215/1609-1175-2019-4-36-38

Abstract

Objective: The study objective is to analyze the efficacy of antibacterial medication selection to treat community-acquired pneumonia (CAP) in children in an out-patient clinic and in a pulmonology department of an in-patient hospital.

Methods: Retrospective descriptive study for 2009–2017 in day-patient departments of pediatric clinics and pediatric pulmonology departments of in-patient hospitals of Primorskiy territory (760 cases).

Results: 50 % of children took antibiotics at pre-hospital stage (self-treatment). Penicillins were the most popular – 50.1 % (218 prescriptions), cephalosporins were used in 129 (29.7 %), macrolides – in 86 (18.8 %) of cases. The average duration of antibacterial treatment course of CAP was 10 days at pre-hospital stage. Both in the out-patient clinic and in the in-patient hospital, cephalosporins (58.4 and 58.3 %), macrolides (34.8 and 37.4 %) and aminoglycosides (6.3 and 3.4 %) were used more often.

Conclusions: The positive dynamics in the protocols of antibiotic therapy of CAP should be noted. The improvement of regulatory framework has led to the increase of rational prescriptions. It is necessary to continue improving of clinical guidelines and implementing pulmonology hospitals of microbiological monitoring that will allow improving the quality of antibacterial treatment.

About the Authors

A. I. Chepurnova
Pacific State Medical University
Russian Federation

Anna I. Chepurnova, MD, postgraduate student, Department of General and Clinical Pharmacology

2 Ostryakova Ave., Vladivostok, 690002



E. V. Eliseeva
Pacific State Medical University
Russian Federation
Vladivostok


Yu. V. Feoktistova
Pacific State Medical University
Russian Federation
Vladivostok


A. V. Kropotov
Pacific State Medical University
Russian Federation
Vladivostok


References

1. WHO. Information bulletin No. 331, November 2014 (In Russ.) URL: http://www.who.int/mediacentre/factsheets/fs331/ru (Accessed: 23 August 2019).

2. Community-acquired pneumonia in children. Clinical Guidelines. Moscow: Originalmaket; 2015. 64 p. (In Russ.).]

3. Shteynberg L.L., Zyryanov S.K., Belousov Yu.B. Clinical and economic assessment of the use of carbapenems (meropenem, imipenem, doripenem) in the treatment of nosocomial pneumonia. Pharmacoeconomics. 2014;7(1):14–8. (In Russ.).

4. On the state of sanitary and epidemiological welfare of the population in the Russian Federation in 2017. State Report. Moscow; 2018. 268 p. (In Russ.).

5. Ansari F, Erntell M, Goossens H, Davey P. The European surveillance of antimicrobial consumption (ESAC) point-prevalence survey of antibacterial use in 20 European hospitals in 2006. Clin Infect Dis. 2009;49(10):1496–504.

6. Malakhov AB, Dronov IA. Indications for use and selection of antibiotic therapy for acute respiratory infections in children on an outpatient basis. Questions of Practical Pediatrics. 2016;11(4):79–84 (In Russ.).

7. Yakovlev SV, Sidorenko SV, Rafalsky VV, Spichak TV. (eds). Strategy and tactics of rational use of antimicrobial agents in outpatient practice. Eurasian Clinical Guidelines. Moscow: Pre100 Print Publishing House; 2016. 144 p. (In Russ.).


Review

For citations:


Chepurnova A.I., Eliseeva E.V., Feoktistova Yu.V., Kropotov A.V. Analysis of the consumption of antibacterial medications in community-acquired pneumonia in children. Pacific Medical Journal. 2019;(4):36-38. (In Russ.) https://doi.org/10.34215/1609-1175-2019-4-36-38

Views: 635


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.


ISSN 1609-1175 (Print)